Should a Psychiatrist or Your Primary Care Doctor Manage Your Antidepressant?
For a first episode of uncomplicated depression or anxiety that is improving on a standard antidepressant, your primary care doctor is usually a reasonable prescriber, and in U.S. commercial insurance data most antidepressant and anti-anxiety prescription fills are written in primary care. A psychiatrist becomes the better choice when the diagnosis is uncertain, two adequate medication trials have not helped, there are signs of bipolar disorder or psychosis, you have suicidal thoughts, you are pregnant or planning pregnancy, or your medication combination is getting complicated.
Many people do well with a middle path: primary care keeps prescribing, and a psychiatrist consults on the plan. The sections below cover where prescribing happens now, the situations that call for a specialist, and how to make the move without a gap in treatment.
Where antidepressants are prescribed today
An analysis of commercial insurance claims by the Health Care Cost Institute, published in March 2026, found that primary care providers wrote about three quarters of antidepressant and anxiolytic prescription fills for people under 65 with employer-sponsored insurance from 2018 to 2022. Earlier federal survey data pointed the same way: in 2005 to 2008, fewer than one-third of Americans aged 12 and over taking a single antidepressant had seen a mental health professional in the past year.
That is not a problem in itself. Primary care clinicians know your medical history, can check for physical causes of low mood, and are often easier to see. The question is which situations need more specialized input.
Does the setting change the results?
Evidence from STAR*D suggests that the quality of care can matter more than the building it happens in. In the STAR*D trial, 2,876 outpatients with nonpsychotic depression were treated with citalopram at 18 primary care and 23 specialty sites, all using the same measurement-based approach: scheduled visits, a treatment manual, and structured ratings of symptoms and side effects at each visit. Remission rates were 26.6% in primary care and 28.0% in specialty care on the Hamilton scale, and response rates were 45.7% and 47.6%, differences the authors found were not significant. They concluded that identical remission and response rates can be achieved in primary and specialty settings when identical care is provided.
The catch is the phrase "identical care." STAR*D patients had research coordinators, set visit schedules and symptom ratings at every visit. Many real-world primary care visits are shorter and less structured. So the useful question is less "primary care or psychiatrist?" and more "will whoever prescribes measure my progress and change course when I am not improving?"
Measuring progress does not require anything elaborate. The PHQ-9, a nine-item questionnaire validated in primary care and obstetrics-gynecology clinics, treats scores of 5, 10, 15 and 20 as thresholds for mild, moderate, moderately severe and severe depression. Repeating it every few weeks gives you and your prescriber a shared number to track; PHQ-9 and GAD-7 scores explained shows how to read the results.
When primary care is a good fit
- A clear diagnosis of depression or an anxiety disorder, without features of bipolar disorder or psychosis.
- Symptoms that are mild to moderate and do not involve suicidal thoughts.
- A first or second antidepressant that is helping with tolerable side effects.
- One psychiatric medication, or a simple, well-understood combination.
- A doctor who follows up regularly, uses a symptom scale, and asks about side effects.
- Access to a therapist, since therapy and medication often complement each other (see medication, therapy or both).
How a first antidepressant is chosen is covered in SSRI, SNRI or bupropion.
Primary care, psychiatrist or collaborative care: a side-by-side view
| Question | Primary care alone | Psychiatrist | Collaborative care in primary care |
|---|---|---|---|
| Who prescribes | Your primary care clinician | The psychiatrist or a psychiatric nurse practitioner | Your primary care clinician, with a psychiatric consultant advising |
| Who follows up between visits | Varies by practice | The psychiatric prescriber, sometimes with a therapist | A behavioral health care manager |
| Strength | Knows your medical history; often easier to see | Depth in diagnosis, complex combinations and treatment-resistant illness | Structured follow-up plus specialist input without leaving primary care |
| Limitation | Visits may be short, and follow-up may be unstructured | Separate appointments; may be out of network | Not every practice offers it |
| Best fit | Uncomplicated depression or anxiety that is improving | Any of the signals in the table above | Depression or anxiety that is not improving fast enough, without red-flag features |
Signals that it is time to see a psychiatrist
| Signal | Why a psychiatrist helps |
|---|---|
| No meaningful response after two adequate trials | Two failed trials at adequate dose and duration is the most common research definition of treatment-resistant depression. Next steps often involve reassessing the diagnosis, augmentation or other treatments. |
| Possible bipolar features | FDA labeling for antidepressants directs prescribers to screen for a personal or family history of bipolar disorder, mania or hypomania before starting treatment. In bipolar disorder, treating a depressive episode with an antidepressant may trigger a mixed or manic episode. |
| Psychotic symptoms | Depression with psychosis usually needs combined treatment and closer monitoring. |
| Suicidal thoughts or past attempts | Needs careful risk assessment, safety planning and often more frequent contact. |
| Pregnancy, planning pregnancy or postpartum | Medication choices weigh risks to both parent and baby; specialist input helps. |
| Complex combinations | Several psychiatric medications at once, or interactions with medical drugs, call for specialist review. |
| Diagnostic doubt | ADHD, trauma, substance use, eating disorders, thyroid disease or sleep disorders can look like depression. |
| Age under 25 | Antidepressants carry an FDA boxed warning for increased suicidal thoughts and behaviors in children and young adults in short-term studies. Closer follow-up early in treatment matters. |
If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.
What "two adequate trials" means
An adequate trial means the medication was taken consistently, at a dose high enough to have a fair chance of working, for long enough to judge. A systematic review for federal health agencies found that experts most often define treatment-resistant depression as at least two prior treatment failures with confirmed adequate dose and duration, but that no single consensus definition exists.
In practice, many "failed" trials were too short, too low a dose, or stopped because of side effects that could have been managed. A psychiatrist will often review your history before concluding a medication did not work. If that is where you are, what a psychiatrist considers after two antidepressants walks through the options, and preparing your medication history shows how to bring the details.
A worked example: when to ask for more help
The timeline below is illustrative, not a treatment plan, and your prescriber may reasonably use a different pace. It shows how the decision points described in guidelines can turn into concrete questions.
| Point in treatment | What guidelines describe | A question to ask |
|---|---|---|
| Starting an antidepressant | NICE in the UK says the first review after starting an antidepressant is usually within 2 weeks, or 1 week for people aged 18 to 25 or at particular risk of suicide, with monitoring of side effects and suicidal thoughts, particularly in the early weeks | "When is my first check-in, and how do I reach you sooner if I feel worse?" |
| No response at all after about four weeks at a recognized therapeutic dose | NICE advises discussing whether other factors, other conditions or problems taking the medication might explain it | "Is the dose high enough, and is something else getting in the way, such as sleep, alcohol or a medical problem?" |
| Little or no response after changes, with no clear cause | NICE lists options including increasing the dose, changing the drug, adding therapy or exercise, and further steps | "Would a psychiatric consultation help us choose the next step?" |
| Two adequate trials without meaningful benefit | The most common research definition of treatment-resistant depression | "Can I be referred to a psychiatrist, or can we set up a consultation?" |
At any point, red-flag features such as suicidal thoughts, possible bipolar symptoms or psychosis move the timeline forward: those warrant prompt specialist input rather than waiting for another trial to run its course.
The middle path: collaborative care
Collaborative care keeps treatment in primary care but adds a care manager and psychiatric consultation. Its most widely cited test is the IMPACT trial, published in JAMA in 2002, which enrolled 1,801 adults aged 60 or older with major depression, dysthymia or both at 18 primary care clinics in five states. Patients had access for up to 12 months to a depression care manager supervised by a psychiatrist and a primary care expert.
At 12 months, 45% of patients in the collaborative care group had at least a 50% reduction in depressive symptoms, compared with 19% in usual care. They also reported more satisfaction with depression care, less functional impairment and better quality of life.
IMPACT was not a one-off. A Cochrane review of collaborative care pooled 79 randomized trials with 24,308 participants and found significantly greater improvement in depression outcomes for adults in the short, medium and long term compared with usual care, and greater improvement in anxiety outcomes as well; the benefit for depression was not demonstrated in the very long term.
Collaborative care is also a recognized, billable service. CMS describes the Psychiatric Collaborative Care Model as a primary care team in which a primary care or other specialty provider and a care manager work with a psychiatric consultant, such as a psychiatrist, and Medicare pays for it under its own codes. Before it starts, the patient must give permission for the practice to consult with specialists, including the psychiatric consultant, and the practice must explain that cost sharing applies.
Questions to ask your primary care practice
- Do you offer collaborative care or integrated behavioral health, and is there a care manager who would check in with me between visits?
- Is there a psychiatrist who reviews cases like mine, and how would I hear about their recommendations?
- Will you use a questionnaire such as the PHQ-9 to track my progress?
- If I am not better by a certain point, what is the next step, and who decides?
- Will my insurance cover the care-management part, and will I have cost sharing for it?
If your primary care practice offers collaborative or integrated behavioral health care, it can be a strong option. If it does not, you can create a version of it yourself by asking for a one-time psychiatric consultation while your primary care doctor continues prescribing (see getting a second opinion on your psychiatric medication).
What good follow-up looks like, wherever you get it
The prescriber's specialty matters less than the quality of follow-up. A family doctor, an internist, a nurse practitioner and a psychiatrist can all meet this standard. These are reasonable things to expect from any of them:
- A check-in within the first few weeks after starting or changing a dose, by visit, phone or portal.
- A standard symptom questionnaire, such as the PHQ-9 for depression, repeated over time so progress is measured rather than guessed.
- Direct questions about side effects, including sleep, sexual function, weight and emotional blunting, which people often do not raise on their own.
- Questions about mood swings, alcohol and other substances, and thoughts of self-harm.
- A plan for what happens if you are not better by a certain point, rather than open-ended waiting.
- A clear answer about how long to stay on the medication once you feel well, and how any future taper would be planned together.
If your current care is missing several of these, that is a reason to ask for more, not necessarily to change doctors. Many primary care practices can add structured follow-up when asked. If they cannot, or if you have already asked and things have not changed, a psychiatric evaluation is a sensible next step. Signs your mental health treatment isn't working lists more warning signs and what to ask for.
Special situations
Teenagers and young adults
Pediatricians and family doctors do treat adolescent depression, with structured guidance. The American Academy of Pediatrics' Guidelines for Adolescent Depression in Primary Care (GLAD-PC) cover youth aged 10 to 21 and recommend active monitoring for mild depression, evidence-based medication and psychotherapy for moderate or severe depression, close monitoring of side effects, and consultation and co-management with mental health specialists. Because of the boxed warning for young people described above, early follow-up is especially important at these ages. Teen depression treatment: a parent's guide covers the choices in more detail.
In New York, primary care clinicians have a specific source of backup. Project TEACH, funded by the New York State Office of Mental Health, lets pediatric primary care providers and maternal health providers speak with a child and adolescent psychiatrist or a reproductive psychiatrist for consultation about their patients. If your child's pediatrician is unsure about a medication question, it is reasonable to ask whether they have used it.
Pregnancy and the year after birth
The U.S. Preventive Services Task Force recommends screening adults for depression, including pregnant and postpartum people. Screening often happens in obstetric or primary care, and many people start treatment there. Specialist input is worth asking for when medication decisions are complicated or symptoms are severe; Project TEACH also supports maternal health providers in New York. Postpartum depression treatment options and what a reproductive psychiatrist does go further.
Older adults
The IMPACT trial described above was conducted in adults aged 60 and older, which makes collaborative care in primary care a well-tested option for this group. Older adults also tend to take more medications for physical conditions, so a psychiatric review is useful when interactions or memory concerns enter the picture; see psychiatric care for an aging parent.
Depression that may be bipolar
If a primary care clinician suspects bipolar disorder, a psychiatric evaluation is the usual next step rather than another antidepressant trial, because antidepressants can trigger a mixed or manic episode in bipolar disorder. Bipolar depression treatment options explains why the approach differs.
Common mistakes
- Staying on the same dose for many months without improvement because no follow-up was scheduled.
- Judging an antidepressant after a week or two, or at a starting dose, and concluding it "did not work."
- Having two clinicians prescribe psychiatric medications without telling each other.
- Leaving out alcohol, cannabis or supplements when asked about other substances.
- Waiting for a referral that never comes. If you think specialist input would help, ask for it directly.
- Stopping medication during a handoff between clinicians, rather than keeping the current prescription until the new prescriber has a plan.
How to raise it with your primary care doctor
Most primary care doctors welcome specialist input on cases that are not improving. You might say: "I have tried two medications and I am still not where I want to be. Would you be comfortable with me seeing a psychiatrist for a consultation?" Ask them to send recent notes and lab results, and bring a list of every medication and dose you have tried.
Keep taking your current medication as prescribed until a new prescriber has a plan. Do not stop or switch on your own, because some antidepressants cause discontinuation symptoms and gaps can lead to relapse. Switching prescribers without a gap explains how to time the handoff.
What changes when a psychiatrist takes over
A psychiatrist will usually start with a longer evaluation that revisits the diagnosis, past episodes, family history, substance use, sleep and medical conditions. Follow-up visits tend to be more frequent while medication is being adjusted. Some people return to primary care once stable; others stay with the psychiatrist long term. Either is reasonable, and ongoing care is described in what ongoing medication management involves.
Handing care back to primary care
If you and the psychiatrist agree that primary care can take prescribing back once you are stable, make the handoff explicit. Ask the psychiatrist for a short letter to your primary care doctor that lists the current medications and doses, what monitoring each needs, which symptoms or side effects should prompt a return referral, and how long they suggest continuing treatment. NICE notes that antidepressant treatment might need to continue for at least 6 months after symptoms remit, with regular review, so the plan for that period should be written down rather than assumed. Keep a copy yourself, and confirm at your next primary care visit that the letter arrived.
For a broader comparison of depression treatments, see a step-by-step integrative plan for depression and the choosing psychiatric care guide.
How this practice handles it
The practice's ongoing care includes psychiatric evaluation and medication management, alongside psychotherapy, coaching, lab testing, and nutrition and lifestyle psychiatry. The team includes psychiatrists, psychiatric nurse practitioners, psychotherapists and a health and wellness coach. Care starts with a free discovery call, where the team answers questions about care options, scheduling and insurance. The practice is out of network with all insurance plans; if you need care that is in network with your plan, ask the team on the discovery call about options. More detail is on the medication management page.
Frequently asked questions
Is it safe to get antidepressants from a primary care doctor?
For many people, yes. In commercial insurance data, primary care clinicians write most antidepressant and anti-anxiety prescriptions. What matters most is regular follow-up, a clear diagnosis, and referral when treatment is not working or the picture is complicated.
Can my primary care doctor and a psychiatrist both be involved?
Yes. A psychiatrist can consult once and send recommendations back, or take over prescribing while your primary care doctor manages your physical health. Make sure only one person is prescribing each psychiatric medication.
How long should I give an antidepressant before deciding it isn't working?
It depends on the medication, the dose and your symptoms. Ask your prescriber how long they expect a fair trial to take at your current dose, and when you should check in if you are not improving.
Do I need a referral to see a psychiatrist?
That depends on your insurance plan and the practice. Some plans require a referral for in-network specialist coverage; out-of-network practices usually do not need one, but your plan's reimbursement rules may still apply.
Will a psychiatrist just add more medications?
Not necessarily. A good psychiatric review may simplify a regimen, adjust doses, reconsider the diagnosis or recommend therapy or other non-medication treatments.
If a psychiatrist takes over, should I keep seeing my primary care doctor?
Yes. Your primary care doctor still manages your physical health, and some psychiatric medications need monitoring that overlaps with it, such as weight, blood pressure or lab tests. Ask both clinicians to share notes so each has the full picture.
Can my primary care doctor prescribe what a psychiatrist recommends?
Often, yes. A one-time psychiatric consultation can end with recommendations that your primary care doctor carries out, as long as they are comfortable with the medication and the monitoring it needs.
Sources
- Primary Care Providers Prescribe the Majority of Antidepressants and Anxiolytics for People with Employer Sponsored Insurance. Health Care Cost Institute, 2026. healthcostinstitute.org
- Antidepressant Use in Persons Aged 12 and Over: United States, 2005-2008 (NCHS Data Brief No. 76). CDC National Center for Health Statistics, 2011. cdc.gov
- Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA (Unützer J et al., IMPACT Investigators), 2002. pubmed.ncbi.nlm.nih.gov
- Defining treatment-resistant depression. Depression and Anxiety (Gaynes BN et al.), 2020. pubmed.ncbi.nlm.nih.gov
- CELEXA (citalopram) prescribing information. U.S. Food and Drug Administration / DailyMed, 2023. dailymed.nlm.nih.gov
- ZOLOFT (sertraline) prescribing information. U.S. Food and Drug Administration / DailyMed, 2023. dailymed.nlm.nih.gov
- Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. Journal of General Internal Medicine (Gaynes BN et al.), 2008. pubmed.ncbi.nlm.nih.gov
- The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine (Kroenke K, Spitzer RL, Williams JB), 2001. pubmed.ncbi.nlm.nih.gov
- Collaborative care for depression and anxiety problems. Cochrane Database of Systematic Reviews (Archer J et al.), 2012. pubmed.ncbi.nlm.nih.gov
- Behavioral Health Integration Services (MLN909432). Centers for Medicare & Medicaid Services, Medicare Learning Network, 2026. cms.gov
- Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management. Pediatrics (Cheung AH et al.), 2018. pubmed.ncbi.nlm.nih.gov
- Project TEACH. Project TEACH (funded by the New York State Office of Mental Health), 2026. projectteachny.org
- Depression and Suicide Risk in Adults: Screening. U.S. Preventive Services Task Force, 2023. uspreventiveservicestaskforce.org
- Depression in adults: treatment and management (NG222), Recommendations. National Institute for Health and Care Excellence, 2022. nice.org.uk
Educational information, not medical, tax or legal advice. Decisions about diagnosis, medication and treatment belong with a clinician who knows your history.
The information provided on this blog is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
A Message From Dr. Lewis If you’ve been struggling with depression or anxiety, I want you to know something important:
The Conversation That Surprised Me A few years ago, I had a patient named Greg who’d been on escitalopram (Lexapro)
You’re Not Meant to Go Through Life Alone In our increasingly connected yet often isolating world, you might sometimes feel